2m 2m 2m 2m 2m 2m 2m
Halozyme Therape (HALO)
NASDAQ
$69.38+$0.39 (+0.57%)
Price as of Jun 23, 2026 3:31 PM EDT- $8.2BMarket Cap
- 30.66%1-Year Change
- BiotechnologyIndustry
Halozyme Therape (HALO)
$69.38+$0.39 (+0.57%)
Earnings Score
Valuation | HALO | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | HALO | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 8.37% | ||
12-Month Momentum | 30.62% | ||
3-Month Risk Adjusted Momentum | 61.43% | ||
12-Month Risk Adjusted Momentum | 105.45% |
True Yield
Valuation | HALO | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.51% | ||
Net Debt Paydown Yield | -0.03% |
Financial Health Score
Valuation | HALO | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |